001     257690
005     20240112171713.0
024 7 _ |a pmc:PMC10647888
|2 pmc
024 7 _ |a 10.1136/svn-2022-001784
|2 doi
024 7 _ |a pmid:36858463
|2 pmid
024 7 _ |a 2059-8688
|2 ISSN
024 7 _ |a 2059-8696
|2 ISSN
024 7 _ |a altmetric:143175226
|2 altmetric
037 _ _ |a DZNE-2023-00487
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Klyscz, Philipp
|0 0000-0003-0058-2365
|b 0
245 _ _ |a Retinal microvascular signs and recurrent vascular events in patients with TIA or minor stroke.
260 _ _ |a London
|c 2023
|b BMJ
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1698411393_2085
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Retinal pathologies are an independent risk factor for ischaemic stroke, but research on the predictive value of retinal abnormalities for recurrent vascular events in patients with prior stroke is inconclusive. We investigated the association of retinal pathologies with subsequent vascular events.In a substudy of the Intensified secondary prevention intending a reduction of recurrent events in TIA and minor stroke patients (INSPiRE-TMS) trial, we enrolled patients with recent transient ischaemic attack (TIA) or minor stroke with at least one modifiable risk factor. Primary outcome was the composite of subsequent vascular events. Retinal photographs were taken at baseline and categorised into three different fundus groups by a telemedically linked ophthalmologist.722 patients participated in the current study and 109 major vascular events occurred. After multivariable adjustments, we did not find a significant association between fundus categories and risk for subsequent vascular events (HRs for moderate vascular retinopathy and vascular retinopathy with vessel rarefaction in comparison to no vascular retinopathy 1.03 (95% CI 0.64 to 1.67), p=0.905 and 1.17 (95% CI 0.62 to 2.20), p=0.626). In a selective post hoc analysis in patients with diabetes mellitus and hypertension, patients with vascular retinopathy with vessel rarefaction had a higher risk for recurrent stroke (HR 24.14 (95% CI 2.74 to 212.50), p=0.004).Retinal changes did not predict major subsequent vascular events in patients with recent TIA or minor stroke. Further studies are needed to examine the utility of fundus photography in assessing the risk of stroke recurrence in patients with diabetes mellitus and hypertension.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a cerebral infarction
|2 Other
650 _ 7 |a ischemic attack, transient
|2 Other
650 _ 7 |a stroke
|2 Other
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Stroke: diagnosis
|2 MeSH
650 _ 2 |a Stroke: epidemiology
|2 MeSH
650 _ 2 |a Stroke: complications
|2 MeSH
650 _ 2 |a Ischemic Attack, Transient: diagnosis
|2 MeSH
650 _ 2 |a Brain Ischemia
|2 MeSH
650 _ 2 |a Hypertension: complications
|2 MeSH
650 _ 2 |a Retinal Diseases: diagnosis
|2 MeSH
650 _ 2 |a Retinal Diseases: epidemiology
|2 MeSH
650 _ 2 |a Retinal Diseases: complications
|2 MeSH
650 _ 2 |a Diabetes Mellitus
|2 MeSH
700 1 _ |a Ihl, Thomas
|b 1
700 1 _ |a Laumeier, Inga
|b 2
700 1 _ |a Steinicke, Maureen
|b 3
700 1 _ |a Endres, Matthias
|0 P:(DE-2719)2811033
|b 4
|u dzne
700 1 _ |a Michelson, Georg
|b 5
700 1 _ |a Audebert, Heinrich J
|b 6
773 _ _ |a 10.1136/svn-2022-001784
|g p. svn-2022-001784 -
|0 PERI:(DE-600)2847692-X
|n 5
|p 379-386
|t Stroke and vascular neurology
|v 8
|y 2023
|x 2059-8688
856 4 _ |u https://pub.dzne.de/record/257690/files/DZNE-2023-00487.pdf
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/257690/files/DZNE-2023-00487.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:pub.dzne.de:257690
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)2811033
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2023
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2022-11-12
915 _ _ |a Creative Commons Attribution-NonCommercial CC BY-NC 4.0
|0 LIC:(DE-HGF)CCBYNC4
|2 HGFVOC
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2022-11-12
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2022-11-12
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2022-11-12
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2023-05-02T08:47:10Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2023-05-02T08:47:10Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2023-05-02T08:47:10Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-10-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-27
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-10-27
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b STROKE VASC NEUROL : 2022
|d 2023-10-27
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b STROKE VASC NEUROL : 2022
|d 2023-10-27
920 1 _ |0 I:(DE-2719)1811005
|k AG Endres
|l Interdisciplinary Dementia Research
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1811005
980 _ _ |a UNRESTRICTED
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21